Synthesis and Molecular Docking Studies of New Tetrazole-acetamide Derivatives as Anti-cancer Agent
Article Sidebar
Main Article Content
Abstract
The chemistry of condensed heterocyclic molecules in terms of their diverse biological properties and role in drug development has been the subject of numerous publications. Tetrazole is a naturally occurring chemical that has been used to create several commercially available drugs and as a result, plays an important role in pharmaceutical chemistry. The current study aimed to create and synthesize seven new 2,5-disubstituted-tetrazole-acetamide derivatives 3a–3g via an N-alkylation reaction of 5-(4-bromophenyl)-2H-tetrazole or 5-(4-chlorophenyl)-2H-tetrazole 1a,1b, and N-acetamide derivatives 2a–2f, and 2g in CH3CN using potassium carbonate as a base in good yields. New molecules were assigned based on nuclear magnetic resonance results (1H, 13C NMR, and two-dimensional-NMR [heteronuclear single quantum coherence spectroscopy [HSQC]), along with mass spectrometry (EI-MS) techniques. The products' biological activities were confirmed using the tetrazolium (MTT) assay against MCF-7 (breast cancer) and PC3 (prostate cancer) cells and their effects on the normal hepatic cell line, WRL68. Results showed that compounds 3e-3g inhibited PC3 cells with average IC50 values of 32.59, 54.99, and 55.53 μM, respectively. Compounds 3a and 3b demonstrated cytotoxicity against the MCF-7 cell line, with average IC50 values of 94.25 and 68.16 μM, respectively. Compounds 3a, 3c, and 3e-3g on the 3ERT and 3ZK6 receptors demonstrated strong binding capabilities and improved protein interactions according to molecular docking experiments.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Cabrele C, Reiser O. The modern face of synthetic heterocyclic chemistry. J Org Chem. 2016; 81(21): 10109-10125.
Hutnick AM, Pokorski JK. Polymeric interventions for microbial infections: a review. Mol Pharm. 2018; 15(8): 2910–2921.
Kerru N, Gummidi L, Maddila S, Gangu KK, Jonnalagadda BS. A review on recent advances in nitrogen containing molecules and their biological applications. Molecules. 2020; 25(8): 1909.
Ashish Ranjan Dwivedi N, Kumar R, Kumar V. Recent synthetic strategies for monocyclic azole nucleus and its role in drug discovery and development. Curr Org Synth. 2018; 15: 321–340.
Sara H, Mohamed H, Anouar A, Hicham B, Najoua B, Salaheddine B, Younas A, Hassane F. Evaluation of the Antibacterial Activity of 5-(thiophen-2-yl)-1H-tetrazole and Its Oxime Derivative against ATCC Reference Strains and Strains Isolated from the Hospital Environment of a Provincial Public Hospital in the City of Fez. Eur J Adv Chem Res. 2021; 2(2): 16-24.
Neochoritis GC, Zhao T, Dömling A. Tetrazoles via multicomponent reactions. Chem Rev. 2019; 119 (3): 1970–2042.
Maher IN, Safaa IE, Manal GM. Synthesis and Study Antimicrobial Activities of Some Novel Tetrazole Derivatives. Egypt J Chem. 2018; 61(1): 197-206.
Mohammed A, Madjid AS, Fatima-Zohra Z, Hocine I. Synthesis of 1,5-Disubstituted Tetrazoles in Aqueous Micelles at Room Temperature. Molbank. 2021; 2021(1): M1194.
Rajendran S, Govindharasu B, Maruthan K, Vediappen P. Synthesis, biological evaluation and in silico studies of tetrazole-heterocycle hybrids. J Mol Struct. 2019; 1175: 577-586.
Harry R, Graham JM, Thomas M, Sotirios T, Irene L, Konstantinos K, Christos TC, Laura KG, Anthony Z, Vasso A, Russell P, Ioannis K, Vassilis GG, John M.M. Discovery of a new generation of angiotensin receptor blocking drugs: Receptor mechanisms and in silico binding to enzymes relevant to SARS-CoV-2. Comput Struct Biotechnol J. 2022; 20: 2091-2111.
Wang SQ, Wang YF, Xu Z. Tetrazole hybrids and their antifungal activities. Eur J Med Chem. 2019; 170: 225-234.
Gao C, Chang L, Xu Z, Yan XF, Ding C, Zhao F, Wu X, Feng LS. Recent advances of tetrazole derivatives as potential anti-tubercular and anti-malarial agents. Eur J Med Chem. 2019; 163: 404-412.
Pooja P, Anand KP, Deepti S, Pradeep SC, Karthik R, Mahendra S, Neena G, Jawahar L, Prem MSC. An insight into tetrahydro-β-carboline–tetrazole hybrids: synthesis and bioevaluation as potent antileishmanial agents. Med Chem Comm. 2017; 8(9):1824-1834.
Kaushik N, Kumar N, Kumar A. Synthesis, antioxidant and antidiabetic activity of 1-[(5-Substituted phenyl)-4, 5-dihydro-1H-pyrazol-3-yl]-5-phenyl-1H-tetrazole. Indian J. Pharm Sci. 2016; 78(3): 352-359.
Younas A, Younas A, Aaziz J, Anouar A, Abdallah EA, Souad EI, Idriss B. Experimental and Computational Studies on N-alkylation Reaction of N-Benzoyl 5-(Aminomethyl)Tetrazole. Chemistry. 2021; 3(3): 704-713.
Sanaa AA, Ruaa MD. Synthesis and Characterization of some Tetrazole Derivatives and Evaluation of their Biological Activity. Egypt J Chem. 2021; 64 (6): 2925-2936.
Julio CFR, Perla IJ, Atilano GC, Mónica ARG, Galdina VSM, Óscar VV, Leticia LR, Eduardo GZ, Alejandro IJ. Synthesis of a Symmetrical tris-Tetrazole as Isostere of a Tricarboxylic Acid: Behind New Tridentate Ligands for MOFs. Chem Proc. 2022; 8(1): 25.
Danil PZ, Adil MK, Valentina IV, Pavel VD, Victor NK, Valentine GN. Efficient synthesis of tetrazole derivatives of cytisine using the azido-Ugi reaction. Tetrahedron. 2018; 74 (32): 4315-4322.
Hamid A, Aamer S, Farukh J, Noor ud D, Ulrich F. Synthesis, single crystal analysis, biological and docking evaluation of tetrazole derivatives. Heliyon. 2018; 4(9): e00792.
Sajjad A. Al Shuhaib Z. Synthesis, Characterization, and Antimicrobial Activity of Some New Tetrazole Derivatives from Hydrazones. Iran J Chem Chem Eng. 2022; 41(7): 2247- 2262.
Neha D, Kamalpreet K, Vikas J. Tetrazoles as anticancer agents: A review on synthetic strategies, mechanism of action and SAR studies. Bioorg Med Chem. 2020; 28(15): 115599.
Javad SG, Soleiman PS, Zohre Z, Hossein SA. Synthesis of 1,5 and 2,5-disubstituted tetrazoles and their evaluation as antimicrobial agents. Nanomed Res J. 2019; 4(2): 91-100.
Zainab AS, Kawkab AH, Sadiq MHI. Synthesis of New Pyrimidine Derivatives, Study of Anti-Сancer Activity, Structural Properties, and Molecular Docking. Russ J Gen Chem. 2023; 93 (5): 1171–1180.
Seta AA, Layla JA, Kawkab AH. Synthesis, Characterisation, and Biological and Computational Studies of Novel Schiff Bases from Heterocyclic Molecules. J Med Chem Sci. 2023; 6(8): 1714-1726.
Laísa C, Hermes DN, Pedro F, Helivaldo S, Aleson S, Francisco AJ, Thamara M, Elba F, Rafael O, Petrônio AF, José BF, Abrahão OF, Edeltrudes L. Potential of 2-Chloro-N-(4-fluoro-3- nitrophenyl) acetamide Against Klebsiella pneumoniae and In Vitro Toxicity Analysis. Molecules. 2020; 25(17): 3959.
Niranjan K, Nitin K, Anoop K, Umesh KS. Tetrazoles: Synthesis and Biological Activity. Immunol Endocr Metab Agents Med Chem. 2018; 18(1): 1-19.
Aysun A, Yağmur K, Yusuf B. Cell Proliferation and Cytotoxicity Assays. Curr Pharm Biotechnol. 2016; 17(14): 1213-1221.
Olivier B, Monika AF, Tuomas W, Gernot B. A Review of Methods to Determine Viability, Vitality, and Metabolic Rates in Microbiology. Front Microbiol. 2020; 11: 547458.
Irum S, Ameer FZ, Azhar R, Asim M, Sajjad A, Zohaib R. Synthesis, Hemolytic Studies, and In Silico Modeling of Novel Acefylline−1,2,4-Triazole Hybrids as Potential Anti-cancer Agents against MCF‑7 and A549. ACS Omega. 2021; 6 (18): 11943-11953.
Deepak JP, Franklin J, Mathew S, Jinju J, Sreehari AP, Bhavya BC. Multicomponent reactions for the synthesis of tetrazole derivatives: Discovery and validation of a novel anticancer agent active against ER positive cancers. Results Chem. 2024; 7: 101470.
Davinder K, Navidha A, Virender K, Harsh K, Aakash D, Shabana B, Hitesh C, Rakesh KM, Abdulrahman A, Metab A, Abdul H. Synthesis, Anticancer, Antimicrobial and Antioxidant Potential of Novel 4-(Substituted phenyl-1,3,4-oxadiazol/thiadiazol-2-yl)-4-(4-substituted phenyl) Azetidin-2-One Derivatives. Pharmaceuticals. 2023; 16(4): 517.
Maruthanila L, Elancheran R, Mirunalini S. Structure-Based Molecular Docking Studies toward Exploring Phytoestrogen against Breast Cancer. Eurasian J Med Oncol. 2022; 6(2):142–149.
Vanathi G, Saraswathy SD. Computational Insights into the Interaction of Pinostrobin with Bcl-2 Family Proteins: A Molecular Docking Analysis. Asian Pac J Cancer Prev. 2024; 25 (2): 507-512.
Baohua Z, Hui L, Kunqian Y, Zhong J. Molecular docking‑based computational platform for high‑throughput virtual screening. CCF Trans High Perform Comput. 2022; 4: 63-74.
Parameshwar R, Harinadha BV, Manichandrika P, Narendra SC JN, Swetha K. Design, synthesis, in silico toxicity prediction, molecular docking, and evaluation of novel pyrazole derivatives as potential antiproliferative agents. EXCLI J. 2016; 15: 187-202.
Heidi SAE, Naglaa IAA, Mohammad AM, Farid AB, Fardous E, Mahmoud BEA, Mohamed AM. Synthesis, In Vitro Antiproliferative Evaluation and Molecular Docking of New tetrazole-chalcone and tetrazole-pyrazoline Hybrids. J Appl Pharm Sci. 2018; 8(5): 75-8.